Who depends on Express Scripts
1 listed supplier reports Express Scripts as a customer worth 10% or more of their revenue, led by Jazz Pharmaceuticals at 42%.
Get an email when Express Scripts's customer concentration changes
When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.
Suppliers that depend on Express Scripts
Listed companies whose annual report names Express Scripts as a customer worth 10% or more of their revenue. If Express Scripts cuts orders or switches supplier, these are the companies that feel it.
| Supplier | Its revenue from this company | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| Jazz PharmaceuticalsJAZZ | 42% | from 42% | 13 years | FY 2025 · filed 24 Feb 2026 |
Formerly disclosed
| Supplier | Its revenue from this company | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| CencoraCOR | 13% | last FY 2024 | 4 years | FY 2024 · filed 26 Nov 2024 |
About this data
US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.
All companies · Latest dependency shifts · Bulk data and API